Patents
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
09/2003
09/03/2003EP1185237B1 Synergistic antibacterial combination
09/03/2003EP1140187B1 Combinations of an ibat inhibitor and a mtp inhibitor for cardiovascular indications
09/03/2003EP1070065B1 Azabicyclic 5ht1 receptor ligands
09/03/2003EP0910372B1 Pharmaceutical compositions containing mesembrine and related compounds
09/03/2003EP0815831B1 Dentifrice composition
09/03/2003EP0772447B1 Chinese herbs extract
09/03/2003EP0767798B1 Sterol derivatives used for regulation of meiosis
09/03/2003CN1119989C Cosmetic compositions for skin and/or hair photoprotection which are based on sinergic mixture of filters and use thereof
09/03/2003CN1119988C Composition for oxidation dyeing of keratin fibres and dyeing process using this composition
09/03/2003CN1119987C Composition for oxidation dyeing of keratin fibres and dyeing process using this composition
09/03/2003CN1119985C Cosmetic composition including acrylic anionic polymer and oxyalkylene silicone
09/02/2003US6613746 Cell adhesion proteins having cells with glycoprotein antibodies and carbohydrate determinants used to interfere with binding FC receptor and as complement inhibitors; antiinflammatory agents
09/02/2003US6613102 As thickening polymer nonionic guar gums; biopolysaccharide gums of microbial origin;
09/02/2003CA2216796C Quinazoline derivatives
08/2003
08/28/2003WO2003070251A1 Pharmaceutical combinations of cox-2 inhibitors and opiates
08/28/2003WO2003070246A1 Controlled synthesis of ziprasidone and compositions thereof
08/28/2003US20030162807 Compositions and methods for treating osteoporosis and lowering cholesterol
08/28/2003US20030162787 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
08/28/2003US20030162749 Use of cdp-choline for the treatment of alcohol withdrawal syndrome
08/28/2003US20030162184 Amplification; polymerase chain reactions
08/28/2003US20030161867 Skin-permeable selective cyclooxygenase-2 inhibitor composition
08/28/2003US20030161834 Adjuvant compositions comprising a saponin and and an immunostimulatory oligonucleotide containing unmethylated CpG (a cytosine guanosine dinucleotide DNA motif); synergistic induction of antigen; anticarcinogenic agents
08/27/2003EP1337279A1 Sterilisation of pharmaceuticals
08/27/2003EP1337271A2 Combination of gaba agonists and sorbitol dehydrogenase inhibitors
08/27/2003CN1439010A Pyrrolo [2,3-d] pyrimidine compounds as immunosuppressive agents
08/27/2003CN1438996A Bicyclic cyclohexylamines and their use NMDA receptor antogonists
08/27/2003CN1438991A Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
08/26/2003US6610665 2-(purin-9-yl)-tetrahydrofuran-3, 4-diol derivatives
08/26/2003US6610332 Antiprotozoa agents; plant extracts
08/26/2003US6610279 Emulsions with naphthalate esters
08/21/2003WO2003068747A1 Nicotinamide derivates useful as p38 inhibitors
08/21/2003WO2003068722A1 Carboxylic acid compounds for use as surfactants
08/21/2003WO2003068193A1 Pharmaceutical composition comprising n- ((1-n-butyl-4-piperidinyl) methyl)-3, 4-dihydro-2h- (1, 3) oxazino (3, 2-a) indole-10-carboxamide or salt and process therefor comprising dry granulation
08/21/2003WO2003068145A2 Herbal immune system stimulant
08/21/2003WO2003032893A3 Assignment
08/21/2003WO2002102308A3 Pharmaceutical composition for the treatment of viral infection
08/21/2003US20030158252 Especially trypsin-like serine proteases, such as chymotrypsin, trypsin, thrombin, plasmin and factor Xa.
08/21/2003US20030158217 Succinate and malonate complexes treatment of abnormal cell growth, such as cancer, and overexpression of erbB2, and inducing cell death
08/21/2003US20030158210 Amino acid ester containing azole antifungals
08/21/2003US20030158206 Sildenafil mesylate for the treatment of male erectile dysfunction or female sexual disorders.
08/21/2003US20030158202 Substituted fused ring sulfonamides containing, e.g., naphthalene, isoquinoline, quinoline, benzofuran or benzothiophene rings; treatment of conditions relating to obesity, type II diabetes and CNS disorders
08/21/2003US20030157138 Pharmaceutical or cosmetic carrier or composition for topical application onto skin and/or mucosal membranes; treatment of skin diseases or disorders including eczema, psoriasis and dermatitis
08/21/2003US20030157032 Antihistamines, bronchodilator agents, antiinflammatory agents; mixture of drug and propellant
08/21/2003US20030156972 Irradiation of ispaghula
08/21/2003CA2475659A1 Pharmaceutical composition comprising n- ((1-n-butyl-4-piperidinyl) methyl)-3, 4-dihydro-2h- (1, 3) oxazino (3, 2-a) indole-10-carboxamide or salt and process therefor comprising dry granulation
08/21/2003CA2474626A1 Carboxylic acid compounds for use as surfactants
08/20/2003EP1336413A1 Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications
08/20/2003EP1335740A1 Method and preparations having effect against allergic symptoms
08/20/2003EP1075258B1 Novel fatty analogues for the treatment of obesity
08/20/2003EP0966295B1 Calcareous material
08/20/2003EP0859591B1 Use of at least one no synthase inhibitor for treating sensitive skin
08/20/2003CN1118571C Active protein with thrombopoietin
08/19/2003US6608068 Substituted indoline derivative compounds which are antagonists of the progesterone receptor; contraceptives; antineoplastic agents
08/19/2003US6608033 Treatment or prevention of coccidiosis
08/19/2003US6607784 Microprecipitation method for preparing submicron suspensions
08/19/2003US6607757 At least 13% glucoside isoflavones and 0.6-1.5 parts 3 soya saponins per 1 part by weight of glucoside isoflavones; treating pre or post menopausal symptoms, breast and prostate cancer, and alcoholism
08/19/2003CA2012414C Hog cholera virus vaccine and diagnostic
08/14/2003WO2003065993A2 Primary rat hepatocyte toxicity modeling
08/14/2003WO2003065990A2 Stenoprophiluric generation and isolation of chemical products
08/14/2003WO2003032973A3 Composition comprising paracetamol and a bitterness masking component
08/14/2003WO2002024145A9 Antiviral substances from plant cuticular and epicuticular material
08/14/2003US20030153757 Synthesis and purification of valacyclovir
08/14/2003US20030153564 New oxabispidine compounds useful in the treatment of cardiac arrhythmias
08/14/2003US20030153544 Fatty acid derivatives
08/14/2003US20030153065 A formulation for maintaining a non-enveloped viral vector containing: trehalose, magnesium chloride, a cationic polymer or a combination, a multiple of non-enveloped viral vector particles and a liquid carrier
08/14/2003US20030153046 Interferon gamma conjugates
08/14/2003US20030152912 Multiple viral replicon culture systems
08/14/2003US20030152535 Cosmetic composition for nails, free of phthalates, camphor and aromatic solvent
08/14/2003CA2474918A1 Stenoprophiluric generation and isolation of chemical products
08/14/2003CA2471631A1 Primary rat hepatocyte toxicity modeling
08/13/2003EP1334727A2 Method for obtaining antigenic structures enhancing specific cross reactivity
08/13/2003EP1334717A2 Pharmaceutical Compositions For Oral And Topical Administration
08/13/2003EP1334363A2 Platelet/leukocyte interaction assay and reagent therefor
08/13/2003EP1333805A2 Cosmetic method of treating skin
08/13/2003EP1132090B1 Method for producing an agent for treating ulcers of the organism
08/13/2003EP1073658B1 Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
08/13/2003EP0987269B1 Salts of optically active sulfoxide derivative
08/13/2003EP0979083B1 Use of 1-ar(alk)yl-imidazolin-2-one for treating anxiety and stress conditions
08/13/2003EP0904092B1 Purified extract of harpagophytum procumbens and/or harpagophytum zeyheri dence, process for its production and its use
08/13/2003CN1436189A Non-nucleoside reverse transcriptase inhibitors
08/13/2003CN1436172A 1,2-dihydropyridine compounds, process for preparation of same and use thereof
08/13/2003CN1117755C Spiroazabicyclic heterocyclic compounds, method for preparing same and use thereof
08/13/2003CN1117732C Noval Dihydronaphthalene compound and process for producing same
08/13/2003CN1117558C Compositions contg. antifungal and sulfur compound
08/12/2003US6605613 Polyene macrolide antibiotic, especially a rapamycin, and an antioxidant, especially 2,6-di-t-butyl-4-methylphenol; 40-O-(2-hydroxy)ethyl-rapamycin in crystalline form.
08/12/2003US6605601 Hypotensive agents; cardiovascular disorders
08/12/2003CA2296373C Composition and method for treating penile erectile dysfunction
08/12/2003CA2286126C Pharmaceutical compositions
08/07/2003WO2003064391A1 Metabolites of (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid
08/07/2003WO2003063842A1 Composition for inhalation
08/07/2003WO2003063797A2 Cycloalkyl inhibitors of potassium channel function
08/07/2003WO2003063783A2 Multiple virus replicon culture systems
08/07/2003WO2003063773A2 Differentially-regulated prostate cancer genes
08/07/2003US20030149091 For therapy of inflammatory bowel disease, ulcerative colitis, pyoderma gangrenosum, Crohn's disease, irritable bowel syndrome, spastic dystonia, chronic pain, acute pain, celiac sprue, pouchitis, vasoconstriction, anxiety, panic disorder
08/07/2003US20030149086 EP4 receptor selective agonists in the treatment of osteoporosis
08/07/2003US20030149065 Arylkylamine spirofuropyridines useful in therapy
08/07/2003US20030148964 Single dose azithromycin
08/07/2003US20030147926 Compositions and methods for transdermal oxybutynin therapy
08/07/2003US20030147922 Vaccine against streptococcus pneumoniae capsular polysaccharides
08/07/2003US20030146145 Mesoporous permeation layers for use on active electronic matrix devices